The hyperactivation of cAMP/PKA/DARPP-32 produced by l-DOPA in the dopamine-depleted striatum results in the dysregulation of multiple signaling pathways ultimately implicated in dyskinesia. The gene discussed is PPP1R1B; the disease is Dyskinesia.